Literature DB >> 13820968

Genetic control of isoniazid metabolism in man.

D A EVANS, K A MANLEY, V A McKUSICK.   

Abstract

Entities:  

Keywords:  ISONIAZID/metabolism

Mesh：

Substances：

Year:  1960        PMID： 13820968      PMCID： PMC2097108          DOI： 10.1136/bmj.2.5197.485

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  16 in total

1.  Comparison of isoniazid concentrations in the blood of people of Japanese and European descent; therapeutic and genetic implications.

Authors:  H W HARRIS; R A KNIGHT; M J SELIN
Journal:  Am Rev Tuberc       Date:  1958-12

2.  A critical analysis of the accuracy of a chemical and biologic method of determining serum free isoniazid.

Authors:  S J BERTE; H C LEIFHEIT; H J DEWLETT; E B TUCKER
Journal:  Am Rev Tuberc       Date:  1959-03

3.  Prophylactic isoniazid: protection of infants in a tuberculosis hospital.

Authors:  B A DORMER; I HARRISON; J A SWART; S R VIDOR
Journal:  Lancet       Date:  1959-11-21       Impact factor: 79.321

4.  Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis.

Authors:  H B HUGHES; J P BIEHL; A P JONES; L H SCHMIDT
Journal:  Am Rev Tuberc       Date:  1954-08

5.  [Enzymatic inactivation of isonicotinic acid hydrizide in human and animal organism].

Authors:  R BONICKE; W REIF
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1953

6.  Distribution and excretion of radioactive isoniazid in tuberculous patients.

Authors:  W R BARCLAY; R H EBERT; G V LE ROY; R W MANTHEI; L J ROTH
Journal:  J Am Med Assoc       Date:  1953-04-18

7.  Tuberculosis chemotherapy with hydrazine derivatives of isonicotinic acid.

Authors:  I J SELIKOFF; E H ROBITZEK
Journal:  Dis Chest       Date:  1952-04

8.  On the lasting protective effect of hydrazine derivatives of isonicotinic acid in the experimental tuberculosis infection of mice.

Authors:  E GRUNBERG; B LEIWANT; I L D'ASCENSIO; R J SCHNITZER
Journal:  Dis Chest       Date:  1952-04

9.  Chemotherapy of human tuberculosis with hydrazine derivatives of isonicotinic acid; preliminary report of representative cases.

Authors:  E H ROBITZEK; I J SELIKOFF; G G ORNSTEIN
Journal:  Q Bull Sea View Hosp       Date:  1952-01

10.  The absorption, distribution, excretion, and short-term toxicity of isonicotinic acid hydrazide (nydrazid) in man.

Authors:  D F ELMENDORF; W U CAWTHON; C MUSCHENHEIM; W McDERMOTT
Journal:  Am Rev Tuberc       Date:  1952-04
View more
  206 in total

1.  Pharmacogenomics. Interview by Clare Thompson.

Authors:  W Sadee's
Journal:  BMJ       Date:  1999-11-13

2.  Prediction of drug response and safety in clinical practice.

Authors:  Andrew A Monte; Kennon J Heard; Vasilis Vasiliou
Journal:  J Med Toxicol       Date:  2012-03

3.  N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism.

Authors:  S P Spielberg
Journal:  J Pharmacokinet Biopharm       Date:  1996-10

Review 4.  Development of analytical technology in pharmacogenetic research.

Authors:  Ann K Daly
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-25       Impact factor: 3.000

5.  Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers.

Authors:  T Graf; F Broly; F Hoffmann; M Probst; U A Meyer; H Howald
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  SOME PRACTICAL APPLICATIONS OF GENETICS IN MEDICINE AND SURGERY.

Authors:  J A ROBERTS
Journal:  Br Med J       Date:  1964-11-14

7.  ENZYMES AND DRUG SENSITIVITY. ACETYLATION POLYMORPHISMS.

Authors:  D A EVANS
Journal:  Proc R Soc Med       Date:  1964-06

8.  Diathesis and disease. The Osler oration, 1963.

Authors: 
Journal:  Can Med Assoc J       Date:  1963-07-06       Impact factor: 8.262

9.  [EEG CHANGES IN A PSYCHOSIS CAUSED BY INH AND AFTER A SUICIDE ATTEMPT WITH NICOTEBEN].

Authors:  S KUBICKI; K IBE; W GOETZE
Journal:  Arch Toxikol       Date:  1964-05-27

10.  Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype.

Authors:  K Carr; J A Oates; A S Nies; R L Woosley
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.